Treatment of Myeloproliferative Neoplasms with Janus Kinase Inhibitors: A Meta-Analysis of Cardiovascular Safety

被引：0
|
作者：
Long, Edouard [1 ]
Dunn, Roberta [1 ]
Li Gagnon, Laura [2 ]
Harrison, Claire [2 ]
Yang, Yunfan [2 ,3 ]
O'Sullivan, Jennifer [4 ]
机构：
[1] Kings Coll London, GKT Sch Med Educ, London, England
[2] Guys & St Thomas NHS Fdn Trust, Dept Haematol, London, England
[3] Sichuan Univ, West China Hosp, Dept Hematol, Chengdu, Peoples R China
[4] Guys & St ThomasNHS Fdn Trust, Dept Clin Haematol, London, England
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-202359
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3168 / 3169
页数：2
相关论文
共 50 条
  • [21] The safety of systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and network meta-analysis
    Carlos Alves
    Ana Penedones
    Diogo Mendes
    Francisco Batel Marques
    European Journal of Clinical Pharmacology, 2022, 78 : 1923 - 1933
  • [22] The safety of systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and network meta-analysis
    Alves, Carlos
    Penedones, Ana
    Mendes, Diogo
    Marques, Francisco Batel
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (12) : 1923 - 1933
  • [23] Erratum: Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond
    Alfonso Quintás-Cardama
    Hagop Kantarjian
    Jorge Cortes
    Srdan Verstovsek
    Nature Reviews Drug Discovery, 2011, 10 : 318 - 318
  • [24] Efficacy and safety of Janus kinase inhibitors in systemic and cutaneous lupus erythematosus: A systematic review and meta-analysis
    Ma, Leyao
    Peng, Liying
    Zhao, Jiuliang
    Bai, Wei
    Jiang, Nan
    Zhang, Shangzhu
    Wu, Chanyuan
    Wang, Li
    Xu, Dong
    Leng, Xiaomei
    Wang, Qian
    Zhang, Wen
    Zhao, Yan
    Tian, Xinping
    Li, Mengtao
    Zeng, Xiaofeng
    AUTOIMMUNITY REVIEWS, 2023, 22 (12)
  • [25] The efficacy and safety of different Janus kinase inhibitors as monotherapy in rheumatoid arthritis: A Bayesian network meta-analysis
    Qu, Bingjia
    Zhao, Feng
    Song, Ying
    Zhao, Junyi
    Yao, Yuxin
    Chen, Yulan
    Liao, Ruobing
    Fu, Lingyu
    PLOS ONE, 2024, 19 (06):
  • [26] Efficacy and safety of Janus kinase inhibitors in patients with psoriasis and psoriatic arthritis: a systematic review and meta-analysis
    Yang, Fan
    Lu, Chaofan
    Wang, Yanhong
    Liu, Huilan
    Leng, Xiaomei
    Zeng, Xiaofeng
    CLINICAL RHEUMATOLOGY, 2023, 42 (06) : 1593 - 1605
  • [27] Efficacy and Safety of Janus Kinase Inhibitors in Chronic Inflammatory Pouch Conditions: A Systematic Review and Meta-analysis
    Alsakarneh, Saqr
    Jaber, Fouad
    Parajuli, Sandesh
    Abboud, Yazan
    Abuelazm, Mohamed
    Hashash, Jana G.
    AMERICAN JOURNAL OF THERAPEUTICS, 2025, 32 (02) : e164 - e166
  • [28] Janus kinase inhibition and symptom control in myeloproliferative neoplasms
    Bose, Prithviraj
    Swaminathan, Mahesh
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (05) : 935 - 937
  • [29] Efficacy and safety of topical Janus kinase and phosphodiesterase inhibitor-4 inhibitors for the treatment of atopic dermatitis: A network meta-analysis
    Zhang, Lu
    Du, Dan
    Wang, Lian
    Guo, Linghong
    Jiang, Xian
    JOURNAL OF DERMATOLOGY, 2021, 48 (12): : 1877 - 1883
  • [30] Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
    Sedeh, Farnam Barati
    Michaelsdottir, Thorunn Elisabet
    Henning, Mattias Arvid Simon
    Jemec, Gregor Borut Ernst
    Ibler, Kristina Sophie
    ACTA DERMATO-VENEREOLOGICA, 2023, 103
12345